The DOI matches its Crossref record; 231 of the 232 references it cites were found in a registry or an index.
Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
Open accessAbstract
The shared role of amyloid-β (Aβ) deposition in cerebral amyloid angiopathy (CAA) and Alzheimer disease (AD) is arguably the clearest instance of crosstalk between neurodegenerative and cerebrovascular processes. The pathogenic pathways of CAA and AD intersect at the levels of Aβ generation, its circulation within the interstitial fluid and perivascular drainage pathways and its brain clearance, but diverge in their mechanisms of brain injury and disease presentation. Here, we review the evidence for and the pathogenic implications of interactions between CAA and AD. Both pathologies seem to be driven by impaired Aβ clearance, creating conditions for a self-reinforcing cycle of increased vascular Aβ, reduced perivascular clearance and further CAA and AD progression. Despite the close relationship between vascular and plaque Aβ deposition, several factors favour one or the other, such as the carboxy-terminal site of the peptide and specific co-deposited proteins. Amyloid-related imaging abnormalities that have been seen in trials of anti-Aβ immunotherapy are another probable intersection between CAA and AD, representing overload of perivascular clearance pathways and the effects of removing Aβ from CAA-positive vessels. The intersections between CAA and AD point to a crucial role for improving vascular function in the treatment of both diseases and indicate the next steps necessary for identifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, brains from COVID patients also show ischemic and hemorrhagic lesions, as well as microglial activation [79], which can be seen in many AD patients with cerebral amyloid angiopathy [80].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Recently, vascular deposits of Aβ peptides (amyloid angiopathy) are increasingly recognized as a common pathology in AD cases, supporting that Aβ peptides circulate within the interstitial fluid, including CSF, and blood vessels through perivascular (e.g. lymphatic) drainage pathways during the crosstalk between the brain and the vascular system [77].”
From Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease (2020) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“Inflammation does, however, not seem to be a major component in CAA-related microhemorrhage or microinfarction [38], with the exception of a rare clinical subtype: CAA-related inflammation [6].”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [6]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“AQP4 levels are reduced in CAA; since AQP4 plays a vital role in glymphatic Aβ clearance in AD brain parenchyma, this consequently impairs Aβ clearance [606, 608].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [608]
In the citing paper
“Chronic inflammation‐induced disruption of the BBB is an early biomarker of human cognitive dysfunction and often leads to dementia, 113 and both Aβ deposits and tau pathology aggravate vascular damage. 114 , 115”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [115]
In the citing paper
“There is overwhelming evidence for cerebrovascular alterations in AD pathology and amyloid-β deposition around leptomeningeal vessels is a hall mark of cerebral amyloid angiopathy, occurring in almost all AD patients”
From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Greenberg et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Sevigny, J., Chiao, P., Bussière, T., Weinreb, P. H., Williams, L., Maier, M., Dunstan, R., Salloway, S., Chen, T., Ling, Y., et al. (2016) · Nature · doi:10.1038/nature19323 · Cited by 3,059
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960
Self-citation
Cited by
Sorted by citations
Items 701–800 of 954
Hayashi, H., Saito, R., Miyashita, A., Ikeuchi, T., Tada, M., Akazawa, K., Onodera, O., Tainaka, K., & Kakita, A. (2026) · Science Advances · doi:10.1126/sciadv.aea7539 · Cited by 1
Sambhariya, W. S., Rickman, C. B., D'Amore, P. A., Corradetti, G., Hageman, G. S., Howell, G. R., Marola, O. J., Phatnani, H. P., Philp, N. J., Sinha, D., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101449 · Cited by 1
Yin, W.-M., He, L.-C., Zhu, H., Cao, Y., Li, A.-M., Wang, Y.-C., & Xu, Y.-M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116407 · Cited by 1
Neurovascular decoupling: An early indicator of cognitive decline
van Dijk, S. E., Drenth, N., Hafkemeijer, A., Draaijer, I., Labadie, G., Witjes‐Ané, M. W., Blauw, G. J., Rombouts, S. A. R. B., van der Grond, J., & van Rooden, S. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261427735 · Cited by 1
Delgado, A., Davidson, K., Parker, D. J., Bryant, J., Winstead, V., Yildiz, M., Pickering, C., & Pickering, A. M. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02040-5 · Cited by 1
Monoclonal antibodies and small molecules: on the cutting edge of Alzheimer’s disease therapy
Ouro, A., Ben-Dor, G. A., Debasa‐Mouce, M., Gulkarov, S., Leon, J. D., Castro‐Mosquera, M., Sobrino, T., Bougea, A. M., & Reiss, A. B. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1766762 · Cited by 1
Izuo, N., Kondoh, H., & Shimizu, T. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70483 · Cited by 1
Ray, N. R., Kurup, J. T., Kumar, A., Rajabli, F., Wang, L., Xu, W., Jin, F., Yılmaz, E., Kızıl, Ç., Nasciben, L. B., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71433 · Cited by 1
Fernández‐Lebrero, A., Jiménez-Baladó, J., García‐Escobar, G., Contador, J., Estragués-Gázquez, I., Peraferrer-Montesinos, L., Suárez‐Pérez, A., Manero-Borràs, R. M., Beltrán, B., Gramegna, L., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70613 · Cited by 1
A plasma protein signature for cerebral amyloid angiopathy
Singh, A., Denkinger, M. N., Leuzy, A., Dieckhoff, K., Liu, J., Marques, T. M., Monuki, E. S., Stark, C., Grill, J. D., Hom, C. L., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03030-5 · Cited by 1
Plasma Amyloid Beta and Tau Associations with Cerebral Amyloid Angiopathy Presence and Severity
Bax, F., Liu, L., van Harten, T. W., Gökçal, E., Horn, M. J., Warren, A., Saba, A., Shirzadi, Z., DiPucchio, Z. Y., Schwab, K. M., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78264 · Cited by 1
Self-citationJoo, L., Lee, J. B., & Yim, Y. (2026) · European Journal of Radiology · doi:10.1016/j.ejrad.2026.112992 · Cited by 1
Bonnar, O., Saadi, F., Sanchez-Mico, M. V., Hanlin, L. H., Eigen, K. A. V., Mumbi, N., Bacskai, B. J., Greenberg, S. M., Holtzman, D. M., & van Veluw, S. J. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00957-x · Cited by 1
Self-citationFeng, X., Bi, S., Shi, C., Chang, Q., Zhang, J. I.-X., & Zhuang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1868789 · Cited by 1
Marshall, C. R., Moser, F. A., Scott, C. F., Ventura‐Antunes, L., Romero‐Fernandez, W., Migas, L. G., Tideman, L. E. M., Colley, M. E., Dufresne, M., Schrag, M., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02361-4 · Cited by 1
Yao, M., Liu, A., Xing, L., Song, J., Yang, Y., Yue, X., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103260 · Cited by 1
Zheng, H., Li, Q., Luo, H., Yuan, Y., Zhang, N., Lu, Y., Duan, S., Zhong, J., Hb, Z., Liu, C. G., et al. (2026) · Advanced Science · doi:10.1002/advs.76761 · Cited by 1
Wang, W., Xu, H., Wu, T., Zhang, Y., Tao, M., Zhao, X., Lu, J., Tang, X., Zhang, S., Zhang, Y., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1870764 · Cited by 1
Curd, B. C., Tolley, N. D., Santo, M., Foster, J., Leardini-Tristão, M., Jacob, S. P., Benzon, H., Ye, X., Shah, S. J., Supiano, M. A., et al. (2026) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-026-03383-4 · Cited by 1
Cell-to-Cell Signaling Networks at the Blood-Brain Barrier in Health and Disease
McCarty, J. H. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324590 · Cited by 1
Khand, Y., Vallamchetla, S. K., Patel, A., Safa, A., Tatit, C. P., Day, G. S., Lin, M., Block, C. K., Tatum, W. O., & Freund, B. E. (2026) · Seizure · doi:10.1016/j.seizure.2026.10.003 · Cited by 1
Stögmann, E., Haider, L., Leinkauf, J., NAKUZ, T. S., Untersteiner, H., Farr, C. V., Silvaieh, S., Parvizi, T., Wurm, R., Kasprian, G. J., et al. (2026) · European Journal of Neurology · doi:10.1111/ene.70779 · Cited by 1
Lemon, N. L., Canepa, E., Vázquez‐Torres, R., Parodi‐Rullán, R. M., Hirt, T., Petersohn, L., Rifat, T., Abyaneh, M. H., Ilies, M. A., & Fossati, S. (2026) · Science Advances · doi:10.1126/sciadv.ady1161 · Cited by 1
Barbato, C., Liuzzi, P., Romoli, A. M., Draghi, F., Maccanti, D., Mannini, A., Macchi, C., Cecchi, F., & Hakiki, B. (2022) · Diagnostics · doi:10.3390/diagnostics12102458 · Cited by 1
Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know
Alsufayan, R., Hess, C. P., & Krings, T. (2023) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7974 · Cited by 1
Sforza, M., Bianchini, E., Alivernini, D., Spalloni, A., Teresi, V., Madonia, I., Salvetti, M., Pontieri, F. E., & Sette, G. (2023) · Neurological Sciences · doi:10.1007/s10072-023-07260-3 · Cited by 1
Research landscape and trends of cerebral amyloid angiopathy: a 25-year scientometric analysis
Wang, K., Zhang, B., Du, H., Duan, H., Jiang, Z., & Fang, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2023.1334360 · Cited by 1
Amyloid angiopathy‐related inflammation: a case report
Alsibai, A., & Tom, J. (2024) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.826 · Cited by 1
Automatic Hemorrhage Detection in Magnetic Resonance Imaging in Cerebral Amyloid Angiopathy
Jesus, T., Palma, C., Oliveira, T. G., & Alves, V. (2024) · Lecture notes in networks and systems · doi:10.1007/978-3-031-45642-8_35 · Cited by 1
Neuropathology of Neurological Disorders
Rather, M. A., Khan, A., Javed, H., Jahan, S., Tabassum, R., & Begum, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_1 · Cited by 1
Prediction of Amyloid Positivity in Patients with Subcortical Vascular Cognitive Impairment
Moon, H., Ham, H., Yun, J., Shin, D., Lee, E. H., Kim, H. J., Seo, S. W., Na, D. L., & Jang, H. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240196 · Cited by 1
Outpatient management of patients with vascular cognitive impairment
Пизова, Н. В., & Pizov, A. V. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-311 · Cited by 1
Sokolova, I. B., & Lobov, G. I. (2024) · Diabetes Mellitus · doi:10.14341/dm13103 · Cited by 1
TESC overexpression mitigates amyloid-β-induced hippocampal atrophy and memory decline
Qi, J., Suo, X., Tian, C., Xia, X., Qin, W., Wang, P., Tang, J., Xu, J., Fu, J., Liu, N., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148939 · Cited by 1
Küster, B., & Kopczak, A. (2024) · Neurologie up2date · doi:10.1055/a-2189-6453 · Cited by 1
Shen, Y., Nie, Q., Xiang, W., Chen, S., Cao, Q., & Hong, D. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251323294 · Cited by 1
A Change of Mind: Targeting Amyloid-β with Better Safety Profile
Krick, K. E., & Wilcock, D. M. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-113434 · Cited by 1
Siriwardhana, C., Carrazana, E. J., & Liow, K. K. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251351216 · Cited by 1
Chen, J., Xie, C., Wu, R., Zhang, D., Wen, F., Nie, H., Xue, L., Zha, Z., & Wang, J. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.112037 · Cited by 1
Anderson, K. E., Bellio, T. A., Aniskovich, E., Adams, S. L., Blusztajn, J. K., & Delalle, I. (2020) · Cerebral Cortex Communications · doi:10.1093/texcom/tgaa031 · Cited by 1
Cognitions and chronic cerebrovascular disease (small vessel disease)
Oros, M. M. (2021) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.5.2021.238526 · Cited by 1
Statins for people with intracerebral hemorrhage
Yan, L., Wang, X., Wang, T., Shu, L., Li, Y., Dmytriw, A. A., Yang, K. Y., Xu, R., Bai, X., Yang, B., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014929 · Cited by 1
Amyloid-β in Brain Aging and Alzheimer’s Disease
Sasaguri, H., & Saido, T. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-7977-3_21 · Cited by 1
Magnetic Resonance Imaging in Pharmaceutical Safety Assessment
Hockings, P. D., & Beckmann, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-73317-9_19-1 · Cited by 1
Gaggero, G., Taietti, D., Parrella, V., & Fiaschi, P. (2023) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.97901 · Cited by 1
Smith, E. E. (2024) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2024.26 · Cited by 1
Zhu, L. J., Wang, M., Liu, Y., Zhang, W., Zhang, H., Roe, A. W., & Wang, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.29.470313 · Cited by 1
Asociaciones entre dieta y función cognitiva en el Proyecto SUN
Muñoz, M. I. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/63292 · Cited by 1
The Winners of the Cerebral Amyloid Angiopathy Epilepsy Prize Are: Blood and Inflammation
Sarkis, R. A. (2024) · Epiliepsy currents/Epilepsy currents · doi:10.1177/15357597231225059 · Cited by 1
Chronic Treatment of a Mouse Model of Cerebral Amyloid Angiopathy and Brain AT 1 Receptor ExpressionPreprint
Noto, N. M., Robison, L. S., & Speth, R. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.16.654535 · Cited by 1
Rezaii, N., Dickson, J., Ford, J. N., He, Y., Katsumi, Y., Ramirez-Gomez, L. A., Lam, A. D., Shah, H., Arnold, S. E., Avetisyan, M., et al. (2026) · medRxiv · doi:10.64898/2026.01.23.26344739 · Cited by 1
Schweitzer, N., Shen, Y., Zhao, Y., Cover, C. G., Alam, S., Deek, R. A., Li, J., Stetten, G., Aizenstein, H. J., Wu, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.06.710077 · Cited by 1
Sloan, L. J., Garceau, D. T., Ryan, N., Pomeroy-Tuck, J., Chidambaram, R., Ragan, T., Pandey, R. S., Bloss, E. B., Carter, G. W., Oblak, A. L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.08.750179 · Cited by 1
Aktuelle Befunde zur Koinzidenz von zerebraler Amyloidangiopathie und Alzheimer-Erkrankung
Haußmann, R., Homeyer, P., Donix, M., & Linn, J. (2021) · Der Nervenarzt · doi:10.1007/s00115-021-01213-x
Redox Processes in the Etiopathogenesis of Cerebrovascular Diseases
Toljan, K. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-84965-8_17
Four cases of suspected cerebral amyloid angiopathy-related inflammation
Tsunoda, K., Wakutani, Y., Shibazaki, K., Ogawa, T., & Takao, Y. (2021) · Nosotchu · doi:10.3995/jstroke.10959
Gupta, S. K., Rutherford, N. K., Dolja‐Gore, X., Watson, T., & Nair, B. (2021) · PubMed Central
Muth, G. A., Harrison, J. S., & Arora, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101476
The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer’s Disease
de Oliveira, F. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-94383-7_3
Biomarkers in cerebrospinal fluid and blood aid diagnosis of dementia
Rosenberg, G. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823455-6.00001-8
Zotin, M. C. Z. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-01122022-122130
Fagiani, F., Fülöp, T., Govoni, S. M., & Lanni, C. (2023) · Biomedicines · doi:10.3390/biomedicines11020484
IMPACTS OF HYPERTENSION AND THROMBOSIS IN A RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY (rTg-DI)
Stanisavljevic, A. (2022) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-stanisavljevic-aleksandra-2022
Implications of a pathophysiological framework for cerebral amyloid angiopathy
Hernández‐Guillamón, M. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00196-5
Krishnakumar, A., Ghadiyaram, A., Patel, V. C., Opalak, C. F., Dixit, N., & Broaddus, W. C. (2023) · Journal of Neurosurgery Case Lessons · doi:10.3171/case23161
Amyloid beta-specific T cell response is enhanced in individuals with mild cognitive impairmentPreprint
Chiu, Y., Yan, S., Fan, Y., Chang, C., Hung, R., Liu, Y., Yang, T. O., & Chuang, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3030193/v1
An overview of cerebral venules: From structure, pathology, and imaging to related diseases
Wang, P., Cao, Y., & Zhu, Y. (2023) · Human Brain · doi:10.37819/hb.1.308
Ioannou, M., Fella, E., Papacharalambous, R., Kynigopoulos, D., & Panayiotou, E. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.07.001
Vervuurt, M., de Kort, A. M., Kersten, I., van Rens, A., Klijn, C. J. M., Schreuder, F. H. B. M., Lefeber, D. J., Kuiperij, H. B., & Verbeek, M. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.15.575618
Julien Bogousslavsky, M. P., Bogousslavsky, J., Paciaroni, M., Hennerici, H., & Tatu, L. (2023) · MDPI eBooks · doi:10.3390/books978-3-0365-2313-2
Atherosclerosis and Alzheimer’s Disease Interconnection: Inflammation, Aβ and More
Poznyak, A. V., Khotina, V. A., Vakili‐Ghartavol, R., Postnov, A. Y., Sukhorukov, V. N., & Orekhov, A. N. (2024) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2024.524.533
Neurological Impact of Type I Interferon Dysregulation
Mylonas, A. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006023
A 73-Year-Old Woman With Confusion, Visual Field Disturbances, and Edematous White Matter Lesions
Rohm, Z., Goldman, M. D., Riley, C., Zamvil, S. S., & Pawate, S. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200300
Kanuri, S. H., & Sirrkay, P. J. (2024) · Neurology Letters · doi:10.61186/nl.3.3.19
Clinical Diagnosis of Alzheimer’s Disease
Güleç, Z. E. K., & Bozluolçay, M. (2024) · doi:10.69860/nobel.9786053359166.5
Genomics of Alzheimer’s disease
Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00035-2
Magnetic Resonance Imaging in Pharmaceutical Safety Assessment
Hockings, P. D., & Beckmann, N. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_19
Zerebrale Amyloidangiopathie und ihre Folgen
Weidauer, S. (2024) · Radiologie up2date · doi:10.1055/a-2339-8420
Unraveling Alzheimer's disease heterogeneity:
Vromen, E. M. (2024) · doi:10.5463/thesis.937
An older man with progressive short-term memory loss and confusion
Reynolds, B., & McLaine, R. (2024) · JAAPA · doi:10.1097/01.jaa.0000000000000151
Wang, G. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815313086124010023
Functional Proteins/Peptides Targeting to Clear Amyloid‐β for Alzheimer's Disease Therapy
Gao, Z., Hou, R., & Qian, C. (2025) · ChemBioChem · doi:10.1002/cbic.202400912
An, D., Li, X., & Xu, Y. Y. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111576
Neuroimaging and Fluid Biomarkers of Alzheimer’s Disease
Gordon, B. A., & Schindler, S. E. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0054
Application of Low Intensity Ultrasound in the Treatment of Alzheimer’s Disease
Hong, F., & Xu, F. (2025) · Advanced ultrasound in diagnosis and therapy · doi:10.37015/audt.2025.240007
Differential Effects of Aβ Peptides on the Plasmin-Dependent Degradation of ApoE3 and ApoE4
Kemeh, M. M., Furnelli, A. J., & Lazo, N. D. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00065
Early Alzheimer’s disease: Clinical overview
Selwood, J., & Coulthard, E. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822240-9.00001-6
Report of a case of spontaneous cerebral hemorrhage due to amyloid angiopathy
Wang, Y., He, Z., Mao, R., & Zhao, Z. (2025) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2025.02.052
Omura, T., Chika, U. S. U. I., Matsushima‐Nishiwaki, R., Kozawa, O., & Tokuda, H. (2025) · Biomedical Research · doi:10.2220/biomedres.46.119
Mechanisms of neurovascular dysfunction in chronic ischemic stroke: insights from sex and aging
Clary, B. L. (2025) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12822
Vascular β-amyloid potentially colocalises with phosphorylated tau in cerebral amyloid angiopathy
Tsai, H.-H. C., Lee, B., Liu, C., Chiang, P., Tsai, Y.-C., Tsai, L., & Peng, S. (2025) · Stroke and Vascular Neurology · doi:10.1136/svn-2024-003774
Wiklund, C., Martola, J., Ollila, H., Kuusela, L., Tiainen, M., & Hästbacka, J. (2025) · Research Square · doi:10.21203/rs.3.rs-6716518/v1
Rohatgi, S., Ford, J. N., Zhu, S., Kozak, B. M., Jahromi, M. V., Griffin, H. R., Chagui, O. G., Dua, A., Calle, E., Farzaneh, H., et al. (2025) · Cureus · doi:10.7759/cureus.85832
Wininger, K. M., Ayasoufi, K., Wolf, D. M., Hinson, D. T., Jin, F., Hansen, M. J., & Johnson, A. J. (2025) · The FASEB Journal · doi:10.1096/fj.202501045r · Cited by 1
Nollet, M., Ba, W., Soto, B. A., Yin, C., Lignos, L., Jović, K., Wong, S., Vyssotski, A. L., Yustos, R., Franks, N. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.663930
TAKAHASHI, T., Yanaka, K., Aiyama, H., Saura, M., Takeda, H., Takahashi, N., Marushima, A., & Ishikawa, E. (2025) · PubMed Central · doi:10.25259/sni_589_2025
Cerebral amyloid angiopathy and endovascular thrombectomy for acute ischemic stroke
Dicpinigaitis, A. J., Martin, H., Bruce, S. S., Merkler, A. E., Liberman, A. L., Chiang, G. C.-Y., Iadecola, C., Knopman, J., Kamel, H., Zhang, C., et al. (2025) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2025.109105
Пизова, Н. В., & Pizov, A. V. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-303
Küster, B., & Kopczak, A. (2025) · Neuroradiologie Scan · doi:10.1055/a-2665-3998
Metadata
- Authors
- Greenberg, S. M., Bacskai, B. J., Hernandez-Guillamon, M., Pruzin, J., Sperling, R., & van Veluw, S. J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Greenberg, Steven M.
- Venue
- Nature Reviews Neurology
- Published
- 2019-12-11
- Volume
- 16
- Issue
- 1
- Pages
- 30-42
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC7268202
- OpenAlex
- W2995183059
- Cited by
- 947
- References
- 232
- Citations by year
- 2026: 146 · 2025: 198 · 2024: 179 · 2023: 154 · 2022: 113 · 2021: 104 · 2020: 52
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG026484)
- National Institute of Neurological Disorders and Stroke (RF1NS110054, R01NS096730, U24NS100591)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- cerebral amyloid angiopathy, Alzheimer's disease, amyloid-beta, amyloid-beta clearance, amyloid-related imaging abnormalities, anti-amyloid immunotherapy, vascular function
- MeSH terms
- Alzheimer Disease, Brain, Humans, Signal Transduction, Amyloid beta-Peptides, Cerebral Amyloid Angiopathy, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
